Variability of clinical and biochemical phenotype in liver phosphorylase kinase deficiency with variants in the phosphorylase kinase (PHKG2) gene
- PMID: 32697758
- DOI: 10.1515/jpem-2019-0603
Variability of clinical and biochemical phenotype in liver phosphorylase kinase deficiency with variants in the phosphorylase kinase (PHKG2) gene
Abstract
Background PHKG2-related liver phosphorylase kinase deficiency is inherited in autosomal recessive pattern and is a rare type of liver glycogenosis. We demonstrated the clinical presentation and genetic determinants involved in children with PHKG2- related liver phosphorylase kinase deficiency. Methodology Ten Pakistani children with liver phosphorylase kinase from seven different families, were enrolled over a period of 18 months. All regions of the PHKG2 gene spanning exons and splicing sites were evaluated through targeted exome sequencing. Variants were analyzed using different bioinformatics tools. Novel variants were reconfirmed by direct sequencing. Results Seven different variants were identified in PHKG2 gene including five novel variants: three stop codons (c.226C>T [p.R76*], c.454C>T [p.R152*] and c.958C>T [p.R320*]), one missense variant c.107C>T (p.S36F) and one splice site variant (c.557-3C>G). All five novel variants were predicted to be damaging by in Silico analysis. The variants are being transmitted through recessive pattern of inheritance except one family (two siblings) has compound heterozygotes. Laboratory data revealed elevated transaminases and triglycerides, normal creatinine phosphokinase and uric acid levels but with glycogen loaded hepatocytes on liver histology. Conclusion PHKG2 related liver phosphorylase kinase deficiency can mimic both liver glycogenosis type I (glucose-6-phosphatase deficiency) & III(amylo-1,6 glucosidase) and characterized by early childhood onset of hepatomegaly, growth restriction, elevated liver enzymes and triglycerides. Molecular analysis would be helpful in accurate diagnosis and proper treatment. The symptoms and biochemical abnormalities in liver glycogenosis due phosphorylase kinase deficiency tend to improve with proper dietary restrictions but need to be monitored for long-term complications such as liver fibrosis and cirrhosis.
Keywords: PHKG2 variant; glycogenosis; liver phosphorylase kinase deficiency.
References
-
- Chena, MA, David, A. Glycogen storage diseases: diagnosis, treatment and outcome. Transl Sci Rare Dis 2016;1:45–72. https://doi.org/10.3233/trd-160006.
-
- Albash, B, Imtiaz, F, Al-Zaidan, H. Novel PHKG2 variant causing GSD IX with prominent liver disease: report of three cases and review of literature. Eur J Pediatr 2014;173:647–53. https://doi.org/10.1007/s00431-013-2223-0.
-
- Chen, MA, Weinstein, DA. Glycogen storage disease: diagnosis, treatment and outcome. Transl Sci Rare Dis 2016;1:45–72. Published: 26 August 2016. https://doi.org/10.3233/trd-160006.
-
- Valladares, AI, Kemlage, LC, Weinstein, DA. Glycogen storage disease. In: Duggan, C, Watkins, JB, Walker, WA, editors. Nutrition in pediatrics 4. Hamilton, Ontario: BC Decker, Inc; 2008, pp. 505–12.
-
- Achouitar, S, Goldstein, JL, Mohamed, M, Austin, S, Boyette, K, Blanpain, FM, et al. Common variant in the PHKA2 gene with variable phenotype in probands with liver phosphorylase b kinase deficiency. Mol Genet Metabol 2011;104:691–4. https://doi.org/10.1016/j.ymgme.2011.08.021.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases